GENMAB A/S -SP ADR
GMABNASDAQEarnings Nov 5US Equity
$30.85▼ $0.02 (−0.06%)
Market closed · at close1h—
24h▼ 0.1%
7d▲ 5.4%
14d▲ 8.2%
30d▲ 7.1%
1y▲ 41.0%
🏦Market Cap
$1.92B
Small Cap
📈Revenue Growth (YoY)
+20.7%
Healthy
📊Gross Margin
93.3%
High
💵FCF Margin
29.0%
Strong
⚖️P/S Ratio
4.7x
Fair
Otter Score
56
Weak
📊
Analyst Ratings
Price
$30.85
Total
18
Raised
4
Lowered
3
Avg PT
$39.08
H / L
$43 / $32
| Institution | Action | Rating | Date |
|---|---|---|---|
TD Cowen | Upgraded | Hold → Buy | 2026-07-22 |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-02 |
Guggenheim | Reiterated | Buy | 2026-02-23 |
Truist Securities | Reiterated | Buy | 2025-11-07 |
William Blair | Upgraded | Market Perform → Outperform | 2025-03-11 |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-02-13 |
BMO Capital | Reiterated | Outperform | 2024-11-08 |
Morgan Stanley | Reiterated | Equal Weight | 2024-09-11 |
JP Morgan | Downgraded | Overweight → Neutral | 2024-08-20 |
RBC Capital | Upgraded | Sector Perform → Outperform | 2024-07-15 |
BTIG | Reiterated | Buy | 2024-06-27 |
HC Wainwright& Co. | Reiterated | Buy | 2023-07-31 |
SVB Leerink | Reiterated | Market Perform | 2023-02-06 |
Jefferies | Downgraded | Buy → Hold | 2021-09-16 |
Bryan Garnier | Downgraded | Neutral → Sell | 2020-09-23 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-06-11 |
Suntrust Robinson Humphrey | Reiterated | Buy | 2020-06-11 |
H.C. Wainwright | Reiterated | Buy | 2020-05-07 |
One row per institution, most recent rating